2. Guidelines on monitoring the impact of the HIV epidemic using population-based surveys. Geneva: World Health Organization (WHO), UNAIDS; 2015.

3. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. When and how to use assays for recent infection to estimate HIV incidence at a population level. Geneva: World Health Organization (WHO), UNAIDS; 2011.

4. WHO Technical Working Group on HIV Incidence Assays: Meeting Report, 2009.

5. WHO/UNAIDS annual meeting of the Technical Working Group on HIV Incidence Assays. 13–15 October 2014, Barcelona, Spain. Geneva: World Health Organization, 2015.

6. Global HIV strategic information working group. Recent infection testing algorithm technical update. Applications for HIV surveillance and programme monitoring, Geneva: World Health Organization (WHO), UNAIDS; 2018.

7. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L. et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17(13): 1871–9. DOI: 10.1097/00002030-200309050-00005

8. Cohen M.S., Gay C.L., Busch M.P., Hecht F.M. The detection of acute HIV infection. J. Infect. Dis. 2010; 202: 270–7. DOI: 10.1086/655651

9. Smoleń-Dzirba J., Wąsik T.J. Current and future assays for identifying recent HIV infections at the population level. Med. Sci. Monit. 2011; 17(5): RA124-133. DOI: 10.12659/msm.881757

10. Murphy G., Parry J.V. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill. 2008; 13(36): 4–10.

11. Moyo S., Wilkinson E., Novitsky V., Vandormael A., Gaseitsiwe S., Essex M. et al. Identifying Recent HIV Infections: From Serological Assays to Genomics. Viruses 2015; (7): 5508–24. DOI: 10.3390/v7102887

12. Kassanjee R., Pilcher C.D., Busch M.P., Murphy G., Facente S.N., Keating S.M. et al. Viral load criteria and threshold optimization to improve HIV incidence assay characteristics. AIDS 2016; 15(30): 2361–71. DOI: 10.1097/QAD.0000000000001209

13. Robinson E., Moran J., O’Donnell K., Hassan J., Tuite H., Ennis O. et al. Integration of a recent infection testing algorithm into HIV surveillance in Ireland: improving HIV knowledge to target prevention. Epidemiology and Infection 2019; 147(e136): 1–7. DOI: https://doi.org/10.1017/ S0950268819000244

14. Janssen R.S., Satten G.A., Stramer S.L., Rawal B.D., O’Brien T.R., Weiblen B.J. et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280(1): 42–8. DOI: 10.1001/jama.280.1.42

15. Suligoi B, Galli C, Massi M., Di Sora F., Sciandra M., Pezzotti P. et al. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J. Clin. Microbiol. 2002; 40: 4015–20. DOI: 10.1128/jcm.40.11.4015-4020.2002

16. Grebe E., Welte A., Hall J., Keating S.M., Facente S.N., Marson K. et al. Infection staging and incidence surveillance applications of high dynamic range diagnostic immunoassay platforms. AIDS 2017; 76(5): 547–55. DOI: 10.1097/QAI.0000000000001537

17. Parekh B.S., Kennedy M.S., Dobbs T., Pau C.-P., Byers R., Green T. et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res. Hum. Retroviruses 2002; 18: 295–307. DOI: 10.1089/088922202753472874

18. Загрядская Ю.Е., Нешумаев Д.А., Кокотюха Ю.А., Мейрманова Е.М., Ольховский И.А., Пузырев В.Ф., Бурков А.Н., Уланова Т.И. Оценка новой тест-системы ДС-ИФА-ВИЧ-АТ-СРОК для определения вероятных сроков заражения вирусом иммунодефицита человека 1-го типа (ВИЧ-1). Эпидемиол. и инфекц. бол. 2015; 20(3): 23–7.

Zagryadskaya Yu.E., Neshumaev D.A., Kokotyukha Yu.A., Meyrmanova E.M.. Olkhovskiy I.A.. Puzyrev V.F.. Burkov A.N.. Ulanova T.I. [Assessment of a new DS-EIA-HIV-AB-TERM assay to determine the probably time of infection with human immunodeficiency virus-1 (HIV-1)]. Epidemiologiya i infektsionnye bolezni 2015; 20(3): 23–7. (In Russ.).

19. Kouyos R., von Wyl V., Yerly S., Böni J., Rieder Ph.A., Joos B. et al. Ambiguous Nucleotide Calls From population based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection. Clin. Infect. Dis. 2011; 52(4): 532–9. DOI: 10.1093/cid/ciq164

20. Киреев Д.Е., Мурзакова А.В., Лопатухин А.Э., Пок­ровская А.В., Шемшура А.Б., Кулагин В.В., Шипулин Г.А., Покровский В.В. Оценка эффективности определения длительности ВИЧ-инфекции путем анализа генетической вариабельности вируса. Инфекционные болезни 2017; 15(2): 61–6. DOI: 10.20953/1729-9225-2017-2-61-66

Kireev D.E., Murzakova A.V., Lopatukhin A.E., Pokrovskaya A.V., Shemshura A.B., Kulagin V.V., Shipulin G.A.. Pokrovskiy V.V. [Assessment of the effectiveness of determining the duration of HIV infection by analysis of viral genetic variability]. Infektsionnye bolezni 2017; 15(2): 61–6. (In Russ.). DOI: 10.20953/1729-9225-2017-2-61-66